Email Newsletters

Life Sciences

Hologic subsidiary releases muscle contraction machine

Cynosure, a division of Marlborough medical device maker Hologic, announced a new product Tuesday using electromagnetic fields to contract and build muscles.

🔒Central Mass. has received $1.7B in NIH funding since 2010

Behind Central Massachusetts biotechnology research taking place to improve brain tumor procedures and genome editing techniques, or...

WPI engineer creating prostate-exam robot receives $2M grant

Worcester Polytechnic Institute professor Haichong Zhang has received a nearly $2-million grant to fund his research into a prostate cancer detecting robot.

Boston Scientific stock jumps on $126M profit report

Marlborough medical device giant Boston Scientific’s stocks rose 6% Wednesday morning after the company reported a $126-million profit on $2.7 billion in sales for the third quarter, exceeding the company’s guidance range for sales.
ADVERTISEMENT

Harvard Bioscience hires new VP from Washington

Holliston biotech Harvard Bioscience on Monday announced Ken Olson has been named vice president and general manager for pre-clinical systems.

Sales director from British multinational to lead Westborough biotech’s marketing

Westborough biotechnology firm Miach Orthopaedics, Inc. has named Michael McNulty its new vice president of sales and...

Arizona biotech moves headquarters to Southborough

Medical device company BioDirection, Inc. has relocated its headquarters from Tuscon, Arizona to Southborough.

Rotmans Furniture holding company announces first spin off

Vystar Corp., the Worcester holding company for Rotmans Furniture and Flooring, has announced it will spin off its RxAir air purifier business in the first-ever spin off for the company.
ADVERTISEMENT

Arch Therapeutics raises $2.5M in RDO

Framingham wound care product manufacturer Arch Therapeutics has raised $2.5 million in a registered direct offering.

Boston hospital president to join Boston Scientific

Marlborough medical company Boston Scientific announced Tuesday that Michael Jaff will join the company as the vice president for clinical affairs, innovation and technology, peripheral interventions by January 2020.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA